Beyond the Digest: March 2025

Beyond the Digest are bonus episodes to the DermSurgery Digest that include reviews of interesting and relevant articles from the Journal of the American Academy of Dermatology (JAAD), British Journal of Dermatology (BJD) and JAMA Dermatology.

Articles featured in this episode include: 

• “Part 1: Management of antithrombotic medications in dermatologic surgery.” JAAD + “Part 2: Management of intraoperative and perioperative bleeding.” JAAD
• “5-fluorouracil 5% cream for squamous cell carcinoma in situ: Factors impacting treatment response.” JAAD
• “Risk of Death Due to Melanoma and Other Causes in Patients With Thin Cutaneous Melanomas.” JAMA Dermatology 
• “Improved disease-specific survival in lentigo maligna treated with Mohs surgery over wide local excision: a retrospective cohort analysis.” BJD, research letter + “Surviving by a margin: Mohs outperforms wide local excision for lentigo maligna.” BJD, commentary on the research letter
• “Thin and in situ melanomas of unfavorable prognosis: A retrospective observational analysis of local recurrence, metastasis, and death in early-stage disease.” JAAD
• “Merkel Cell Carcinoma and Immunosuppression, UV Radiation, and Merkel Cell Polyomavirus.” JAMA Dermatology
• “Reduction of masseter muscle prominence after treatment with onabotulinumtoxinA: Primary results from a randomized phase 2 study.” JAAD
• “Improvement of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial.” JAAD

 Beyond the Digest Contributors include Naomi Lawrence, MD, Dermatologic Surgery Digital Content Editor; Yesul Kim, MD, Beyond the Digest Co-host; Ami Greene, MD; Tara Jennings, MD; Payvand Kamrani, DO; Sydney Proffer, MD; Kathryn Shahwan, MD; and Yssra Soliman, MD.

 Your feedback is encouraged. Please contact communicationstaff@asds.net.